Aimfinity Investment CORP I 8-K filings

Aimfinity Investment Corp. I supplements its proxy statement with new independent director nominees and reports initial product shipments for Docter Inc.

Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination by two months, utilizing a promissory note from its sponsor to fund the extensions.

Aimfinity Investment Corp. I secured a one-month extension to March 28, 2026, for its business combination with Docter Inc., funded by a $500 promissory note from its sponsor's designee.

Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination with Docter Inc. to February 28, 2026, via a $500 promissory note from its sponsor's designee.

Aimfinity Investment Corp. I secured a one-month extension to January 28, 2026, for its business combination with Docter Inc. by depositing $500 into its trust account.

Aimfinity Investment Corp. I secured a one-month extension to complete its business combination with Docter Inc., pushing the deadline to December 28, 2025.

Aimfinity Investment Corp. I has extended its deadline to complete a business combination with Docter Inc. until November 28, 2025, while facing significant shareholder redemptions.

Aimfinity Investment Corp. I shareholders approved an extension to complete its business combination with Docter Inc. and removed a net tangible asset requirement.

Aimfinity Investment Corp. I issued a supplement to its proxy statement, clarifying redemption procedures for its upcoming Extraordinary General Meeting and extending the redemption request deadline.

Aimfinity Investment Corp. I has terminated its previous agreement to acquire Inkrock Holding Limited and entered into a new securities purchase agreement, aligning the acquisition with its business combination with Docter Inc.

Aimfinity Investment Corp. I has secured its ninth and final monthly extension to complete its business combination with Docter Inc. until October 28, 2025.

Aimfinity Investment Corp. I has secured an eighth monthly extension to complete its business combination with Docter Inc., pushing the deadline to September 28, 2025, via a $55,823.8 promissory note.

Aimfinity Investment Corp. I announced new financing for its business combination with Docter Inc. through promissory notes and a seventh monthly extension to complete the merger, amidst significant shareholder redemptions and pro forma losses.

Aimfinity Investment Corp. I has secured a one-month extension for its business combination with Docter Inc. until July 28, 2025, by issuing a $55,823.8 promissory note to its sponsor's designee, I-Fa Chang.

Aimfinity Investment Corp. I (AIMUF) announced shareholder approval for its business combination with Docter Inc., revealing updated pro forma financial statements that reflect net losses and significant public share redemptions.

Aimfinity Investment Corp. I (AIMUF) has filed an 8-K detailing the financial arrangements for its business combination with Docter Inc., including the settlement of deferred underwriting commissions and conversion of significant loans into equity.

Aimfinity Investment Corp. I announced a strategic acquisition of a Washington State property valued at $8.3 million from its CEO's controlled entity, alongside securing a $55,823.8 promissory note from the CEO to fund a fifth monthly extension for its business combination with Docter Inc. until June 28, 2025.

Aimfinity Investment Corp. I will begin trading on the OTC Market on May 5, 2025, after receiving a delisting notice from Nasdaq due to non-compliance with listing standards.

Aimfinity Investment Corp. I (AIMA) will transition to the OTC Markets after failing to meet Nasdaq's business combination deadline, while also securing a one-month extension to finalize its merger with Docter Inc.

Aimfinity Investment Corp. I (AIMA) has entered into exchange agreements to convert outstanding notes into private units and PubCo ordinary shares as part of transaction financing to support its business combination with Docter Inc.

Aimfinity Investment Corp. I's shareholders approved the business combination with Docter Inc., and the company extended its deadline to complete the merger by one month to April 28, 2025.

Aimfinity Investment Corp. I and Docter Inc. announce that the SEC has declared effective the registration statement for their business combination, marking a significant step towards finalizing the merger.

Aimfinity Investment Corp. I secures a one-month extension to complete its initial business combination by depositing $55,823.8 into its trust account.

Aimfinity Investment Corp. I (AIMAU) announced an amendment to the earnout structure of its proposed business combination with Docter Inc. and the appointment of Dr. Jonathan Tien to the post-merger board.

Aimfinity Investment Corp. I and Docter Inc. have amended their merger agreement, shifting the earnout milestones for Docter stockholders to later fiscal years.

Aimfinity Investment Corp. I extends its deadline for an initial business combination to February 28, 2025, by depositing $55,823.8 into its trust account.

Aimfinity Investment Corp. I secures shareholder approval to extend the deadline for completing an initial business combination to October 28, 2025, with monthly extension options.

Aimfinity Investment Corp. I has revised the terms for extending its business combination deadline, increasing the required contribution to the trust account to $0.05 per public share for each one-month extension.

Aimfinity Investment Corp. I has adjourned its extraordinary general meeting to January 9, 2025, and extended the deadline for shareholders to submit redemption requests to January 8, 2025.

Aimfinity Investment Corp. I has extended its deadline to complete a business combination to January 28, 2025, by issuing a $60,000 promissory note to its sponsor.